% layout 'default';
% if ($currentLanguage eq 'en') {
% title 'OPENVAET - Pfizer Clinical Phase 3 Trial - Reviewing the numbers communicated to the FDA & NEJM';
% } else {
% title 'OPENVAET - Essais cliniques de phase 3 Pfizer - Revue des chiffres communiqués à la FDA et au NEJM';
% }
<head>
    <link rel="stylesheet" href="https://unpkg.com/leaflet@1.9.2/dist/leaflet.css" integrity="sha256-sA+zWATbFveLLNqWO2gtiw3HL/lh1giY/Inf1BJ0z14=" crossorigin="" />
    <script src="https://unpkg.com/leaflet@1.9.2/dist/leaflet.js" integrity="sha256-o9N1jGDZrf5tS+Ft4gbIK7mYMipq9lqpVJ91xHSyKhg=" crossorigin=""></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet.draw/0.2.3/leaflet.draw.js"></script>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet.draw/0.2.3/leaflet.draw.css">
    <!-- jQuery -->
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.6.0/jquery.min.js"></script>
    <link href="/css/select2.min.css" rel="stylesheet" />
    <script src="/js/select2.min.js"></script>
</head>

% my %dose1Sites = %$dose1Sites;
% my %dose2Sites = %$dose2Sites;
<div class="content-container" style="padding-left:30px;padding-right: 30px;width: calc(100% - 60px);max-width: 1400px;">
    <div class="text_separator"></div>
    % if ($currentLanguage eq 'en') {
    <div class="url-link noselect" onclick="openLocation('/studies');return;">&#10229; Return to studies</div>
    <h2>Introduction</h2>
    Most interesting articles were brought to our attention, by the DailyClout's team 3, Jeyanthi Kunadhasan, MD (<a href="https://gettr.com/user/Jkun85" target="_blank">Gettr</a>), Ed Clark, MSE, and Chris Flowers, MD (<a href="https://gettr.com/user/chrisflowersmd" target="_blank">Gettr</a>), and by anonymous whistle-blower Arkmedic (<a href="https://t.me/arkmedic" target="_blank">Telegram</a> | <a href="https://gab.com/arkmedic" target="_blank">Gab</a> | <a href="https://arkmedic.substack.com/" target="_blank">Substack</a>), highlighting multiple abnormalities in the "Pfizer vaccine trial".
    <div class="text_separator"></div>
    Benefiting from their precious insights, and desiring to verify and to be able to support their figures, we dived in with Geoff Pain, PHD  (<a href="https://gettr.com/user/GeoffPainPhD" target="_blank">Gettr</a>), and are sharing here our preliminary findings, which, we hope, will simplify the accessibility of the data for other researchers who may want to study this capital clinical trial.
    <div class="text_separator"></div>
    People desiring to study the trial may also benefit from the reading of this report of interest by Christine Cotton, <a href="https://christine-cotton.1ere-page.fr/wp-content/uploads/2022/03/ENG-Vaccine-expertise-GCP-CCotton-2022-02-14-v2_AC.pdf" target="_blank">"Evaluation of the methodological practices implemented in the Pfizer/BioNtech" trials in the development of its COVID-19 RNA-messenger vaccine in relation to Good Clinical Practices"</a>, on this trial, whose summary <a href="https://twitter.com/StatChrisCotton/status/1598398931381223440" target="_blank">you can find here</a>.
    <h2>Preliminary facts reminder</h2>
    The Pfizer/BionTech vaccine <b>"efficacy of 95%"</b> was announced, through the press, on November 18, 2020, as per example this New-York Times Article, <a href="https://www.nytimes.com/2020/11/18/health/pfizer-covid-vaccine.html" target="_blank">New Pfizer Results: Coronavirus Vaccine Is Safe and 95% Effective</a>.
    <div class="text_separator"></div>
    On November 20, 2020, as exposed on the <a href="https://www.fda.gov/media/144416/download" target="_blank">Emergency Use Authorization (EUA) for an Unapproved Product Review Memorandum</a>, the submission process for the EUA began. This process <a href="https://www.fda.gov/media/144245/download" target="_blank">took some time and ended on December 10, 2020</a>.
    <div class="text_separator"></div>
    On December 11, 2020, a day later, <a href="https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm?s_cid=mm6950e2_w" target="_blank">the EUA was granted by the FDA</a>.
    <div class="text_separator"></div>
    Some of the <b>key dates</b> are summarized in the Timeline below.
    <div class="text_separator"></div>
    <div class="text_separator"></div>
	<div style="width:100%;overflow-x: auto;">
		<img src="/doc/pfizer_trials/TimelinePfizer.png">
	</div>
    <div class="text_separator"></div>
    <div class="text_separator"></div>
    In the paper <a href="https://www.nejm.org/doi/full/10.1056/nejmoa2034577" target="_blank">Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine</a>, published on December 31, 2020 in the New England Journal of Medicine (NEJM.org), by Fernando P. Polack & al., the World saw for the first time some details on the numbers backing this claim.
    <div class="text_separator"></div>
    As established by the document <a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-publications.pdf&currentLanguage=<%=$currentLanguage%>">pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-publications.pdf</a>, page 31 & following, the study was finalized on December 16, 2020. This document also includes the previous studies published.
    <div class="text_separator"></div>
	<a href="https://phmpt.org/court-documents/" target="_blank">PHMPT's FOI & lawsuits</a> allowed the public to access the documents which were supposed to stay hidden for 75 years, and which are supporting the FDA EUA & the NEJM study.
    <div class="text_separator"></div>
    This data is therefore partially available, even if <b>key files required to reproduce the original code, such as the ADSL file, are still not provided</b> when this study is written, on November 26, 2022.
    <div class="text_separator"></div>
    This lack of transparency hasn't evolved despite <a href="https://www.bmj.com/content/378/bmj.o1731/rr-1" target="_blank">this recent letter from Peter Doshi to the BMJ</a> on October 07, 2022.
    <div class="text_separator"></div>
	The <b>Data Cut-off dates</b> featured in the NEJM study are unclear, therefore are summarized briefly.
	<ul>
		<li>Efficacy subset data cut-off was <b>November 14</b> - but given 7 days were required post dose 2, no patient injected post November 08 was included</li>
		<div class="text_separator"></div>
		<li>Safety subset data cut-off was <b>October 9</b> (at least 2 months of follow-up post dose 1)</li>
	</ul>
	The stated <b>Interval between injections</b> of 21 days between injections, in the NEJM study, is misleading. As illustrated in the protocol & an FDA table, the delay is in reality an interval of <b>19 to 42 days</b>, as brought to our attention by The DailyClout's team 3's <a href="https://dailyclout.io/report-41-the-170-clinical-trial-participants-who-changed-the-world-pfizer-ignored-protocol-deviations-to-obtain-emergency-use-authorization-for-its-covid-19-mrna-vaccine/" target="_blank">Report 42: Pfizer’s EUA Granted Based on Fewer Than 0.4% of Clinical Trial Participants. FDA Ignored Disqualifying Protocol Deviations to Grant EUA</a>.
	<div class="text_separator"></div>
	This article also highlights several abnomalies which we encourage researchers to review.
	<div class="text_separator"></div>
	<a href="/studies/pfizer_trial_cases_mapping?currentLanguage=<%=$currentLanguage%>">We mapped these cases</a>, which only highlighted the importance of site 1231, led by the NEJM study's lead author, Fernando Polack. <a href="/studies/verifying_170_cases?currentLanguage=<%=$currentLanguage%>">We verified the listing of the subjects sustained for the efficacy case</a> located by the DailyClout team 3</a>, and desired to calculate the infection rate by site.
    <div class="text_separator"></div>
    It must also be precised, as mentioned page 24 of <a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-050222/125742_S1_M5_c4591001-S-csdrg.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">this document</a> that "virtual sites" were created and integrated in the patient "unique id". It's of importance as site 4444, virtual site of site 1231, often appears in the efficacy results.
	<div class="text_separator"></div>
	Last, as it had been already highlighted by Arkmedic (in one of his many former (censored) Twitter incarnations, <a href="https://t.me/jikkyleaks">Jikkyleaks</a>), every swab analysis was made in the Pfizer's Pearl River laboratory in New York - even if local analysis had been performed by the lab.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div onclick="openInNewTab('/doc/pfizer_trials/1231ToCentralLab.png');return;" style="width:400px;display:block;margin:auto;cursor: pointer;"><img src="/doc/pfizer_trials/1231ToCentralLab.png" style="width:400px;display:block;margin:auto;"></div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	This central lab prevalence is highlighted in the <a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">Protocol from March 2, 2021</a>, while this precision doesn't figure in the November 27, 2020 <a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf&currentLanguage=<%=$currentLanguage%>">version of the protocol</a>.
	<div class="text_separator"></div>
	When a conflict was arising between the central laboratory results & the local laboratory result, the sole results sustained were the central laboratory results.
	<div class="text_separator"></div>
    <h2>Methodology</h2>
    Data has been automatically downloaded from the PHMPT's website, extracted & converted to processible files. The code has been written <a href="/data?currentLanguage=<%=$currentLanguage%>" target="_blank">using Perl 5</a>.
    <div class="text_separator"></div>
    The scripts & data are freely accessible, and detailed further in the <b>Methodology Details</b> section. Additional libraries (open source & freely accessible) have been documented when required.
    <div class="text_separator"></div>
    <h2>Results</h2>
    <div class="text_separator"></div> 
	We dispose to date, of several type of useful sources in our attempts de reproduce the NEJM study calculations:
	<ul>
		<li>260 PDF Documents, detailed in the <a href="/doc/pfizer_trials/pfizer_pdf_files_subjects.xlsx" download>following .XLSX file</a></li>
		<li>70 XPT Files, detailed in the <a href="/doc/pfizer_trials/pfizer_sas_files_subjects.xlsx" download>following .XLSX file</a></li>
		<li>27 XLSX Files, dumps from SAS files</li>
	</ul>
    <div class="text_separator"></div>
    This papper focused on reproducting the figures communicated to the NEJM by Pfizer & Biontech as far as efficacy was concerned. It led us to highlight that the figures featured in the NEJM study & in the FDA memorandum are vague, and sometimes contradicting each others (1)</b>.
    <div class="text_separator"></div>
	Most of the population figures featured in the study are in no way reproductible given the current state of the data and are <b>highlighting multiple anomalies</b> (2).
    <div class="text_separator"></div>
    Last, it's unclear why some patients haven't been included in the efficacy data while they appear to have tested positive prior the data cut-off.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 15px);padding-left: 15px;font-size: 20px;font-weight: bold;">
	    1 - Disreptencies in NEJM & FDA figures.
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	We summarized the following disreptancies (in red) and similitudes (in green) between the FDA submission & the NEJM figures. 
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div onclick="openInNewTab('/doc/pfizer_trials/NEJM_FDA_Consort_Diagram.png');return;" style="width:800px;display:block;margin:auto;cursor: pointer;"><img src="/doc/pfizer_trials/NEJM_FDA_Consort_Diagram.png" style="width:800px;display:block;margin:auto;"></div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	As highlighted, the randomization data doesn't correspond, with <b>103 more subjects</b> in the FDA memorandum.
	<div class="text_separator"></div>
	While we can correlate 43 448 subjects as "injected with a vaccine or placebo", figures established based on this basis are impossible to reproduce.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 15px);padding-left: 15px;font-size: 20px;font-weight: bold;">
	    2 - Reconstituting general population figures.
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	The multiple files used to reproduce the population figures are summarized in the following diagram. 
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div onclick="openInNewTab('/doc/pfizer_trials/PopulationMap.png');return;" style="width:800px;display:block;margin:auto;cursor: pointer;"><img src="/doc/pfizer_trials/PopulationMap.png" style="width:800px;display:block;margin:auto;"></div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	<ul>
		<li>Two SAS files are keeping track of <b>48 091 subjects</b> initiations.</li>
		<ul>
			<div class="text_separator"></div>
			<li>FDA-CBER-2021-5683-0169082-to-0171523_125742_S1_M5_c4591001-S-D-suppdm.xpt</li>
			<div class="text_separator"></div>
			<li>FDA-CBER-2021-5683-0171524-to-0174606_125742_S1_M5_c4591001-S-D-suppds.xpt</li>
		</ul>
		<div class="text_separator"></div>
		<li>3108 of these subjects aren't appearing in any PDF file. A list of "44 982 subjects likely to have been screened" was generated parsing the PDF & SAS files - but this figure may include some rare duplicate subjects. When no screening date was documented, we evaluated it based in the display order of the .XPT file, after verifying that it was indeed incremental for the <b>44 404 subjects</b> for whom screening dates were known. The last subject (subject 44442322) also appears in the PDF demographic file as the last subject recruited by virtual site 4444 (site 1231) on <b>September 27, 2020</b>.</li>
		<div class="text_separator"></div>
		<li>We can speculate, based on this data, that the "44 820 subjects screened" quoted in NEJM Table's 1 has been established only integrating the sources with a green background. <b>Why subjects who are present in lab analysis for malignancies, cerebrovascular issues, leukemia, tumors or lymphomaes would have been excluded from the "screening scope" is unclear.</b></li>
		<div class="text_separator"></div>
		<li>Randomization data has been extracted for the PDF files. When no randomization data was available (102 subjects appearing in the ADVA files), the randomization date has been set to the first vaccination date (as it's the case for most subjects). <b>It's unclear why we have a 5 subjects offset with the FDA Memorandum; and therefore a 108 subjects offset with the NEJM ones.</b></li>
		<div class="text_separator"></div>
		<li>The doses injected have been built using the randomization PDF files & the ADVA XPT file. It's unclear why <b>102 subjects</b> of the ADVA files aren't appearing in the Randomization files - along with why 27 subjects from the randomization files aren't in the ADVA file.</li>
	</ul>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 15px);padding-left: 15px;font-size: 20px;font-weight: bold;">
	    3 - Reconstituting efficacy subset figures.
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	The subjects corresponding, according to the criterion determined by the protocol, to the efficacy subset. 
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div onclick="openInNewTab('/doc/pfizer_trials/EfficacyDiagram.png');return;" style="width:800px;display:block;margin:auto;cursor: pointer;"><img src="/doc/pfizer_trials/EfficacyDiagram.png" style="width:800px;display:block;margin:auto;"></div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
    	3.1 - Doses 1 Administered, Demographic characteristics
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	Basic demographic characteristics of the subjects who received a first dose of either BNT162b2 or Placebo are represented in the following table.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width: calc(100% - 75px);max-width:162px;margin-left: 5px;">
        <select class="js-example-basic-single" id="siteTargetDose1Demographic" style="width: 95%;height: 95%;">
        % for my $totalSubjects (sort{$b <=> $a} keys %dose1Sites) {
            % for my $trialSiteId (sort{$a <=> $b} keys %{$dose1Sites{$totalSubjects}}) {
                % my $trialSiteName = $dose1Sites{$totalSubjects}->{$trialSiteId}->{'trialSiteName'} // die;
                % my $trialSitePostalCode = $dose1Sites{$totalSubjects}->{$trialSiteId}->{'trialSitePostalCode'};
                % if ($trialSitePostalCode) {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%>, <%=$trialSitePostalCode%> | <%=$totalSubjects%> subjects</option>
            	% } else {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%> | <%=$totalSubjects%> subjects</option>
        		% }
            % }
        % }
        </select>
    </div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    <div style="width:100%;word-break: break-word;" id="mapDemographicDose1">
    </div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
	    3.2 - Doses 1 Administered, Week by week 
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width: calc(100% - 75px);max-width:162px;margin-left: 5px;">
        <select class="js-example-basic-single" id="siteTargetDose1Week" style="width: 95%;height: 95%;">
        % for my $totalSubjects (sort{$b <=> $a} keys %dose1Sites) {
            % for my $trialSiteId (sort{$a <=> $b} keys %{$dose1Sites{$totalSubjects}}) {
                % my $trialSiteName = $dose1Sites{$totalSubjects}->{$trialSiteId}->{'trialSiteName'} // die;
                % my $trialSitePostalCode = $dose1Sites{$totalSubjects}->{$trialSiteId}->{'trialSitePostalCode'};
                % if ($trialSitePostalCode) {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%>, <%=$trialSitePostalCode%> | <%=$totalSubjects%> subjects</option>
            	% } else {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%> | <%=$totalSubjects%> subjects</option>
        		% }
            % }
        % }
        </select>
    </div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    <div style="width:100%;word-break: break-word;" id="weekByWeekContainerDose1">
    </div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	As you can verify for yourself using the above filter, <b>it's unclear how site 1231, who enrolled so much more subjects than the other sites, was able to achieve completion of its schedule in just 52 days (most of the doses being injected within a 3 weeks window)</b>, while the other sites completed their doses schedule within multiple weeks in the overall 110 days period (excluding site 1231, within <b>an average period of 64 days</b>).
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div onclick="openInNewTab('/doc/pfizer_trials/Site1231Dose1.png');return;" style="width:800px;display:block;margin:auto;cursor: pointer;"><img src="/doc/pfizer_trials/Site1231Dose1.png" style="width:800px;display:block;margin:auto;"></div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
    	3.3 - Doses 1 Administered, Mapping by sites
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	The following map illustrates the total of subjects injected with dose 1, by site. You can display only one specific site using the filter.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width: calc(100% - 75px);max-width:162px;margin-left: 5px;">
        <select class="js-example-basic-single" id="siteTargetDose1Map" style="width: 95%;height: 95%;">
        % for my $totalSubjects (sort{$b <=> $a} keys %dose1Sites) {
            % for my $trialSiteId (sort{$a <=> $b} keys %{$dose1Sites{$totalSubjects}}) {
                % my $trialSiteName = $dose1Sites{$totalSubjects}->{$trialSiteId}->{'trialSiteName'} // die;
                % my $trialSitePostalCode = $dose1Sites{$totalSubjects}->{$trialSiteId}->{'trialSitePostalCode'};
                % if ($trialSitePostalCode) {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%>, <%=$trialSitePostalCode%> | <%=$totalSubjects%> subjects</option>
            	% } else {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%> | <%=$totalSubjects%> subjects</option>
        		% }
            % }
        % }
        </select>
    </div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    <div style="width:100%;word-break: break-word;" id="mapContainerDose1">
    </div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
    	3.4 - Subjects up to November 8, within 19 to 42 days post dose 1, without Covid 7 days post dose 2, Demographic characteristics
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	Basic demographic characteristics of the subjects who received a first dose of either BNT162b2 or Placebo are represented in the following table.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width: calc(100% - 75px);max-width:162px;margin-left: 5px;">
        <select class="js-example-basic-single" id="siteTargetDose2Demographic" style="width: 95%;height: 95%;">
        % for my $totalSubjects (sort{$b <=> $a} keys %dose2Sites) {
            % for my $trialSiteId (sort{$a <=> $b} keys %{$dose2Sites{$totalSubjects}}) {
                % my $trialSiteName = $dose2Sites{$totalSubjects}->{$trialSiteId}->{'trialSiteName'} // die;
                % my $trialSitePostalCode = $dose2Sites{$totalSubjects}->{$trialSiteId}->{'trialSitePostalCode'};
                % if ($trialSitePostalCode) {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%>, <%=$trialSitePostalCode%> | <%=$totalSubjects%> subjects</option>
            	% } else {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%> | <%=$totalSubjects%> subjects</option>
        		% }
            % }
        % }
        </select>
    </div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    <div style="width:100%;word-break: break-word;" id="mapDemographicDose2">
    </div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
	    3.5 - Subjects up to November 8, within 19 to 42 days post dose 1, without Covid 7 days post dose 2, Week by week 
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width: calc(100% - 75px);max-width:162px;margin-left: 5px;">
        <select class="js-example-basic-single" id="siteTargetDose2Week" style="width: 95%;height: 95%;">
        % for my $totalSubjects (sort{$b <=> $a} keys %dose2Sites) {
            % for my $trialSiteId (sort{$a <=> $b} keys %{$dose2Sites{$totalSubjects}}) {
                % my $trialSiteName = $dose2Sites{$totalSubjects}->{$trialSiteId}->{'trialSiteName'} // die;
                % my $trialSitePostalCode = $dose2Sites{$totalSubjects}->{$trialSiteId}->{'trialSitePostalCode'};
                % if ($trialSitePostalCode) {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%>, <%=$trialSitePostalCode%> | <%=$totalSubjects%> subjects</option>
            	% } else {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%> | <%=$totalSubjects%> subjects</option>
        		% }
            % }
        % }
        </select>
    </div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    <div style="width:100%;word-break: break-word;" id="weekByWeekContainerDose2">
    </div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
    	3.6 - Subjects up to November 8, within 19 to 42 days post dose 1, without Covid 7 days post dose 2, Mapping by sites
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	The following map illustrates the total of subjects injected with dose 1, by site. You can display only one specific site using the filter.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width: calc(100% - 75px);max-width:162px;margin-left: 5px;">
        <select class="js-example-basic-single" id="siteTargetDose2Map" style="width: 95%;height: 95%;">
        % for my $totalSubjects (sort{$b <=> $a} keys %dose2Sites) {
            % for my $trialSiteId (sort{$a <=> $b} keys %{$dose2Sites{$totalSubjects}}) {
                % my $trialSiteName = $dose2Sites{$totalSubjects}->{$trialSiteId}->{'trialSiteName'} // die;
                % my $trialSitePostalCode = $dose2Sites{$totalSubjects}->{$trialSiteId}->{'trialSitePostalCode'};
                % if ($trialSitePostalCode) {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%>, <%=$trialSitePostalCode%> | <%=$totalSubjects%> subjects</option>
            	% } else {
                <option value="<%=$trialSiteId%>"><%=$trialSiteName%> | <%=$totalSubjects%> subjects</option>
        		% }
            % }
        % }
        </select>
    </div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    <div style="width:100%;word-break: break-word;" id="mapContainerDose2">
    </div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 15px);padding-left: 15px;font-size: 20px;font-weight: bold;">
	    4 - Confirmed Covid-19 cases among eligible efficacy subset
	</div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    First, we evaluated the infection rate, by trial site country, by subjects' days of exposure satisfying the efficacy criterion (7 days post dose 2).
    <div class="text_separator"></div>
    <div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
    	4.1 - Subjects with a confirmed Covid-19 swab
	</div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    The <b>214 subjects confirmed for Covid 19</b> by a swab & a PCR test, to data cut-off on November 14, 2020, and satisfying the conditions for eligibility, are detailed below.
	<div class="text_separator"></div>
	When they haven't been included in the NEJM 170 subjects, they are highlighted in yellow.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:100%;word-break: break-word;overflow-x: auto;" id="positiveSwabsSubjects">
    	
    </div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    <div style="width:calc(100% - 15px);padding-left: 15px;font-size: 20px;font-weight: bold;">
	    5 - Methodology Details
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
	    5.1 - PHPMT Files Download & Extraction
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	You'll need the <a href="https://www.xpdfreader.com/download.html" target="_blank">XPDF version corresponding to your OS</a>. Place the file (either pdftohtml on Linux or pdftohtml.exe on Windows) in your project repository.
	<div class="text_separator"></div>
	You must answer "Y" when the script asks you if it should proceed with the extraction of the .PDF files, if you want to reproduce the global PDF statistics.
	<div class="text_separator"></div>
	We automatically downloaded the documents from the Pfizer trials made available on <a href="https://phmpt.org/pfizers-documents/" target="_blank">PHMPT.org</a>, using the script <a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_documents/get_documents.pl" target="_blank">tasks/pfizer_documents/get_documents.pl</a> (Github), and converted the .PDF files to .HTML using the same script.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
	    5.2 - Global files analysis
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	The original data from the trial was generated from the Software "SAS", and is delivered in several .XPT files.
	<div class="text_separator"></div>
	XPT is a proprietary format constraining you to have SAS installed.
	<div class="text_separator"></div>
	We extracted all the XPT files prefixed "FDA-CBER-2021-5683" (Documented on <a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-050222/125742_S1_M5_bnt162-01-A-adrg.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">this PDF document, page 17 & following</a>), using the Github project <a href="https://github.com/WizardMac/ReadStat" target="_blank">ReadStat</a>.
	<div class="text_separator"></div>
	We used the script <a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/subjects_in_sas_files.pl" target="_blank">tasks/pfizer_trials/subjects_in_sas_files.pl</a> to analyze the XPT files (having converted these to .CSV first) and build an overview of the data available on each of the <b>48 091 subjects</b> presents in the 70 XPT files.
	<div class="text_separator"></div>
	We used the script <a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/subjects_in_pdf_files.pl" target="_blank">tasks/pfizer_trials/subjects_in_pdf_files.pl</a> to analyze the PDF files (having converted these to .html first) and build an overview of the data available on each of the <b>46 959 subjects</b> presents in the 260 PDF files.
	<div class="text_separator"></div>
	All of the patients present in PDF files are present in some XPT files. On another hand, <b>3 275 subjects</b> are in SAS but nowhere in the .PDF files.
	<div class="text_separator"></div>
	The last subject (subject 44442322) also appears in the PDF demographic file as the last subject recruited by virtual site 4444 (site 1231) on September 27, 2020.
	<div class="text_separator"></div>
	 which, if the order of addendum in this log is incremental, leaves the question of what happened to these 3 275 subjects opened.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 45px);padding-left: 45px;font-size: 18px;font-weight: bold;">
	    5.3 - Key Files Extraction
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	Several files, have been sustained as key in the analysis.
	<div class="text_separator"></div>
    <div style="width:calc(100% - 75px);padding-left: 75px;font-size: 16px;font-weight: bold;">
	    5.3.1 - SAS ADVA File
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	<a href="https://pdata0916.s3.us-east-4.amazonaws.com/pdocs/050222/FDA-CBER-2021-5683-0123168+to+-0126026_125742_S1_M5_c4591001-A-D-adva.zip" target="_blank">FDA-CBER-2021-5683-0123168+to+-0126026_125742_S1_M5_c4591001-A-D-adva.zip</a> results in an adva.csv file (114 365 entry points, on <b>46 448 patients</b>), which we converted to a more friendly <a href="/doc/pfizer_trials/pfizer_adva_patients.json" download>.JSON</a>, using the <a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/extract_adva_data.pl" target="_blank">tasks/pfizer_trials/extract_adva_data.pl</a> script.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div style="width:calc(100% - 75px);padding-left: 75px;font-size: 16px;font-weight: bold;">
	    5.3.2 - PDF Files
	</div>
	<div class="text_separator"></div>
	Something one has to understand about the Pfizer trial documents released by PHMPT is that we have several editions of the same tables, which are completed by Pfizer & communicated to the FDA as the trial went along.
	<div class="text_separator"></div>
	<div class="text_separator"></div>
	For example, there are several editions of the table "16.2.8.1":
	<div class="text_separator"></div>
	- One is labelled <i>"16.2.8.1 Listing of Subjects With Postvaccination SARS-CoV-2 NAAT-Positive Nasal Swab and COVID-19 Signs andSymptoms – Dose 1 All-Available Efficacy Population"</i>, which you can find in the file "pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf", finalized on November 24, 2020.
	<div class="text_separator"></div>
	- One is labelled <i>"16.2.8.1 Listing of Subjects With First COVID-19 Occurrence After Dose 1 – Blinded Placebo-Controlled Follow-up Period – Dose 1 All-Available Efficacy Population"</i>, which you can find in the file "pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-lab-measurements-sensitive.pdf", finalized on April 1, 2021
	<div class="text_separator"></div>
	The files extracted are summarized in the table below.
	<div class="text_separator"></div>
	<div style="width: 100%;overflow-x: auto;overflow-y: auto;text-align: center;border: 1px solid black;box-sizing: border-box;font-size: 13px;">
		<div style="min-width:1890px;width:100%;display: flex;flex-wrap: wrap;font-weight: bold;padding-top: 15px;">
			<div style="width: 20%;">
				File Name
			</div>
			<div style="width: 20%;">
				Table Name
			</div>
			<div style="width: 10%;">
				Pages
			</div>
			<div style="width: 15%;">
				Extraction Script (Github)
			</div>
			<div style="width: 25%;">
				Notes
			</div>
			<div style="width: 10%;">
				Output
			</div>
		</div>
		<div style="min-width:1890px;width:100%;display: flex;flex-wrap: wrap;margin-top: 15px;padding-top: 15px;border-top: 1px solid black;">
			<div style="width: 20%;">
				<a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdf</a>
			</div>
			<div style="width: 20%;">
				16.2.4 Listing of Demographic Characteristics – All Subjects ≥16 Years of Age
			</div>
			<div style="width: 10%;">
				1 to 2951
			</div>
			<div style="width: 15%;">
				<a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/extract_trial_demographics_1.pl" target="_blank">tasks/pfizer_trials/extract_trial_demographics_1.pl</a>
			</div>
			<div style="width: 25%;">
				Demographic table containing 44 257 subjects data (aged 16 or older).
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_demographics_1.csv" download>.CSV</a>
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_demographics_1.json" download>.JSON</a>
			</div>
		</div>
		<div style="min-width:1890px;width:100%;display: flex;flex-wrap: wrap;margin-top: 15px;padding-top: 15px;border-top: 1px solid black;">
			<div style="width: 20%;">
				<a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-demographics.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-demographics.pdf</a>
			</div>
			<div style="width: 20%;">
				16.2.4.4 Listing of Demographic Characteristics – All Subjects
			</div>
			<div style="width: 10%;">
				22 to 3139
			</div>
			<div style="width: 15%;">
				<a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/extract_trial_demographics_2.pl" target="_blank">tasks/pfizer_trials/extract_trial_demographics_2.pl</a>
			</div>
			<div style="width: 25%;">
				Demographic table containing 43 646 subjects data (aged 16 or older).
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_demographics_2.csv" download>.CSV</a>
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_demographics_2.json" download>.JSON</a>
			</div>
		</div>
		<div style="min-width:1890px;width:100%;display: flex;flex-wrap: wrap;margin-top: 15px;padding-top: 15px;border-top: 1px solid black;">
			<div style="width: 20%;">
				<a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf</a>
			</div>
			<div style="width: 20%;">
				16.1.7.1 Listing of Randomization Scheme and Actual Vaccine Received – All Subjects ≥16 Years of Age
			</div>
			<div style="width: 10%;">
				1 to 4376
			</div>
			<div style="width: 15%;">
				<a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/extract_randomization_scheme.pl" target="_blank">tasks/pfizer_trials/extract_randomization_scheme.pl</a>
			</div>
			<div style="width: 25%;">
				Randomization table containing 44 360 subjects assigned groups & doses received.
			</div>
			<div style="width: 5%;">
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_randomization.json" download>.JSON</a>
			</div>
		</div>
		<div style="min-width:1890px;width:100%;display: flex;flex-wrap: wrap;margin-top: 15px;padding-top: 15px;border-top: 1px solid black;">
			<div style="width: 20%;">
				<a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf</a>
			</div>
			<div style="width: 20%;">
				16.2.1.1 Listing of Subjects Discontinued From Vaccination and/or From the Study – All Subjects ≥16 Years of Age
			</div>
			<div style="width: 10%;">
				1 to 229
			</div>
			<div style="width: 15%;">
				<a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/extract_exclusions_1.pl" target="_blank">tasks/pfizer_trials/extract_exclusions_1.pl</a>
			</div>
			<div style="width: 25%;">
				Exclusions Table containing 1 862 exclusions.
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_exclusions_1.csv" download>.CSV</a>
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_exclusions_1.json" download>.JSON</a>
			</div>
		</div>
		<div style="min-width:1890px;width:100%;display: flex;flex-wrap: wrap;margin-top: 15px;padding-top: 15px;border-top: 1px solid black;">
			<div style="width: 20%;">
				<a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf</a>
			</div>
			<div style="width: 20%;">
				16.2.1.2 Listing of Subjects Discontinued From Vaccination and/or From the Study – Subjects Enrolled in Multiple Sites – All Subjects ≥16 Years of Age
			</div>
			<div style="width: 10%;">
				231 to 232
			</div>
			<div style="width: 15%;">
				<a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/extract_exclusions_2.pl" target="_blank">tasks/pfizer_trials/extract_exclusions_2.pl</a>
			</div>
			<div style="width: 25%;">
				Exclusions Table containing 8 valid exclusions, and a few without dates details.
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_exclusions_2.csv" download>.CSV</a>
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_exclusions_2.json" download>.JSON</a>
			</div>
		</div>
		<div style="min-width:1890px;width:100%;display: flex;flex-wrap: wrap;margin-top: 15px;padding-top: 15px;border-top: 1px solid black;">
			<div style="width: 20%;">
				<a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf</a>
			</div>
			<div style="width: 20%;">
				16.2.8.2.IA1 Listing of Subjects With First COVID-19 Occurrence From 7 Days After Dose 2 and Without Evidence of Infection Prior to 7 Days After Dose 2 – Evaluable Efficacy Population (7 Days) – Interim Analysis 1
			</div>
			<div style="width: 10%;">
				586 to 602
			</div>
			<div style="width: 15%;">
				<a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/extract_efficacy_cases_2.pl" target="_blank">tasks/pfizer_trials/extract_efficacy_cases_2.pl</a>
			</div>
			<div style="width: 25%;">
				Interim Lab Measurements file containing 94 positive cases, sustained for efficacy calculation when the file was edited.
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_efficacy_cases_2.csv" download>.CSV</a>
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_efficacy_cases_2.json" download>.JSON</a>
			</div>
		</div>
		<div style="min-width:1890px;width:100%;display: flex;flex-wrap: wrap;margin-top: 15px;padding-top: 15px;padding-bottom:15px;border-top: 1px solid black;">
			<div style="width: 20%;">
				<a href="/pfizearch/viewer?pdf=pfizer_documents/native_files/pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf&currentLanguage=<%=$currentLanguage%>" target="_blank">pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf</a>
			</div>
			<div style="width: 20%;">
				16.2.8.2 Listing of Subjects With First COVID-19 Occurrence From 7 Days After Dose 2 and Without Evidence of Infection Prior to 7 Days After Dose 2 – Evaluable Efficacy (7 Days) Population
			</div>
			<div style="width: 10%;">
				66 to 99
			</div>
			<div style="width: 15%;">
				<a href="https://github.com/OpenVaet/openvaet/blob/main/tasks/pfizer_trials/extract_efficacy_cases.pl" target="_blank">tasks/pfizer_trials/extract_efficacy_cases.pl</a>
			</div>
			<div style="width: 25%;">
				Interim Lab Measurements file containing 170 positive cases, sustained for efficacy calculation when the file was edited.
				<div class="text_separator"></div>
				Subject <b>[C4591001 1093 10931122]</b> doesn't appear in this table while page 591 of the previous file, and we found no satisfying explanation to her disappearance.
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_efficacy_cases.csv" download>.CSV</a>
			</div>
			<div style="width: 5%;">
				<a href="/doc/pfizer_trials/pfizer_trial_efficacy_cases.json" download>.JSON</a>
			</div>
		</div>
	</div>
	<div class="text_separator"></div>
	<div class="text_separator"></div>
    <div class="text_separator"></div>
    <div class="text_separator"></div>
    <div class="text_separator"></div>
    <div class="text_separator"></div>
    <div class="text_separator"></div>
    <div class="text_separator"></div>
    % } else {
    % }
</div>
<script type="text/javascript" src="/js/charts_loader.js"></script>

<script type="text/javascript">
    var chartWidth     = document.getElementById("weekByWeekContainerDose1").clientWidth;
    console.log('chartWidth     : ' + chartWidth);

    var lat = 14.974135;
    var lng = -79.404801;

    // center of the map
    var center    = [lat, lng];
    var zoomLevel = 2;

    $( document ).ready(function() {

        // Loads top bar.
        setDropDowns();
        loadWeekByWeekDose1();
        loadMappingDose1();
        loadDemographicDose1();
        loadWeekByWeekDose2();
        loadMappingDose2();
        loadDemographicDose2();
        loadEfficacyCases();
    });

    function setDropDowns() {

        $('#siteTargetDose1Week').select2({
            width: 'element',
            height: 'resolve',
            dropdownAutoWidth : true
        });
        $('#siteTargetDose1Week').on("select2:select select2:unselect", function(e) {
            loadWeekByWeekDose1();
        });
        $('#siteTargetDose1Map').select2({
            width: 'element',
            height: 'resolve',
            dropdownAutoWidth : true
        });
        $('#siteTargetDose1Map').on("select2:select select2:unselect", function(e) {
            loadMappingDose1();
        });
        $('#siteTargetDose1Demographic').select2({
            width: 'element',
            height: 'resolve',
            dropdownAutoWidth : true
        });
        $('#siteTargetDose1Demographic').on("select2:select select2:unselect", function(e) {
            loadDemographicDose1();
        });
        $('#siteTargetDose2Week').select2({
            width: 'element',
            height: 'resolve',
            dropdownAutoWidth : true
        });
        $('#siteTargetDose2Week').on("select2:select select2:unselect", function(e) {
            loadWeekByWeekDose2();
        });
        $('#siteTargetDose2Map').select2({
            width: 'element',
            height: 'resolve',
            dropdownAutoWidth : true
        });
        $('#siteTargetDose2Map').on("select2:select select2:unselect", function(e) {
            loadMappingDose2();
        });
        $('#siteTargetDose2Demographic').select2({
            width: 'element',
            height: 'resolve',
            dropdownAutoWidth : true
        });
        $('#siteTargetDose2Demographic').on("select2:select select2:unselect", function(e) {
            loadDemographicDose2();
        });
    }

    function loadWeekByWeekDose1() {
        $("#weekByWeekContainerDose1").html("");
        let siteTarget = $('#siteTargetDose1Week').val();
        let request = $.ajax({
            url: "/review_nejm_fda_data/load_dose_1_week_by_week",
            type: "POST",
            data: {
                siteTarget      : siteTarget,
                mainWidth       : mainWidth,
                mainHeight      : mainHeight,
                currentLanguage : currentLanguage
           }
        });

        request.done(function(data) {
            $("#weekByWeekContainerDose1").html(data);
        });

        // Printing error message if case of failure
        request.fail(function(jqXHR, textStatus) {
            alert("Something went wrong : " + textStatus)
        });
    }

    function loadMappingDose1() {
        $("#mapContainerDose1").html("");
        let siteTarget = $('#siteTargetDose1Map').val();
        let request = $.ajax({
            url: "/review_nejm_fda_data/load_dose_1_mapping",
            type: "POST",
            data: {
                siteTarget      : siteTarget,
                mainWidth       : mainWidth,
                mainHeight      : mainHeight,
                currentLanguage : currentLanguage
           }
        });

        request.done(function(data) {
            $("#mapContainerDose1").html(data);
        });

        // Printing error message if case of failure
        request.fail(function(jqXHR, textStatus) {
            alert("Something went wrong : " + textStatus)
        });
    }

    function loadDemographicDose1() {
        $("#mapDemographicDose1").html("");
        let siteTarget = $('#siteTargetDose1Demographic').val();
        let request = $.ajax({
            url: "/review_nejm_fda_data/load_dose_1_demographic",
            type: "POST",
            data: {
                siteTarget      : siteTarget,
                mainWidth       : mainWidth,
                mainHeight      : mainHeight,
                currentLanguage : currentLanguage
           }
        });

        request.done(function(data) {
            $("#mapDemographicDose1").html(data);
        });

        // Printing error message if case of failure
        request.fail(function(jqXHR, textStatus) {
            alert("Something went wrong : " + textStatus)
        });
    }

    function loadWeekByWeekDose2() {
        $("#weekByWeekContainerDose2").html("");
        let siteTarget = $('#siteTargetDose2Week').val();
        let request = $.ajax({
            url: "/review_nejm_fda_data/load_dose_2_week_by_week",
            type: "POST",
            data: {
                siteTarget      : siteTarget,
                mainWidth       : mainWidth,
                mainHeight      : mainHeight,
                currentLanguage : currentLanguage
           }
        });

        request.done(function(data) {
            $("#weekByWeekContainerDose2").html(data);
        });

        // Printing error message if case of failure
        request.fail(function(jqXHR, textStatus) {
            alert("Something went wrong : " + textStatus)
        });
    }

    function loadMappingDose2() {
        $("#mapContainerDose2").html("");
        let siteTarget = $('#siteTargetDose2Map').val();
        let request = $.ajax({
            url: "/review_nejm_fda_data/load_dose_2_mapping",
            type: "POST",
            data: {
                siteTarget      : siteTarget,
                mainWidth       : mainWidth,
                mainHeight      : mainHeight,
                currentLanguage : currentLanguage
           }
        });

        request.done(function(data) {
            $("#mapContainerDose2").html(data);
        });

        // Printing error message if case of failure
        request.fail(function(jqXHR, textStatus) {
            alert("Something went wrong : " + textStatus)
        });
    }

    function loadDemographicDose2() {
        $("#mapDemographicDose2").html("");
        let siteTarget = $('#siteTargetDose2Demographic').val();
        let request = $.ajax({
            url: "/review_nejm_fda_data/load_dose_2_demographic",
            type: "POST",
            data: {
                siteTarget      : siteTarget,
                mainWidth       : mainWidth,
                mainHeight      : mainHeight,
                currentLanguage : currentLanguage
           }
        });

        request.done(function(data) {
            $("#mapDemographicDose2").html(data);
        });

        // Printing error message if case of failure
        request.fail(function(jqXHR, textStatus) {
            alert("Something went wrong : " + textStatus)
        });
    }

    function loadEfficacyCases() {
        $("#positiveSwabsSubjects").html("");
        let request = $.ajax({
            url: "/review_nejm_fda_data/load_efficacy_cases",
            type: "POST",
            data: {
                mainWidth       : mainWidth,
                mainHeight      : mainHeight,
                currentLanguage : currentLanguage
           }
        });

        request.done(function(data) {
            $("#positiveSwabsSubjects").html(data);
        });

        // Printing error message if case of failure
        request.fail(function(jqXHR, textStatus) {
            alert("Something went wrong : " + textStatus)
        });
    }
</script>